ViiV Healthcare to present new long-term findings from its innovative 2-drug and long-acting HIV medicines portfolio at CROI 2022Data reinforce ViiV Healthcare’s leadership and commitment to developing ground-breaking medicines for HIV treatment and prevention London, 7 February 2022 – ViiV Healthca.
Data reinforce ViiV Healthcare's leadership and commitment to developing ground-breaking medicines for HIV treatment and prevention ViiV Healthcare, the global specialist HIV company majority-owned
New Delhi [India], June 5 (ANI): Poor mental health, disruptions to education, loss of income and violence, are some of the worrying consequences of COVID-19, according to a survey based on experiences of women and young people across different contexts and regions.